FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885658755> ?p ?o ?g. }

• W2885658755 endingPage "2949" @default.
• W2885658755 startingPage "2943" @default.
• W2885658755 abstract "Hypofractionated radiotherapy delivers larger daily doses of radiation and may increase the biologically effective dose delivered to the prostate. We conducted a randomized trial testing the hypothesis that dose-escalated, moderately hypofractionated intensity-modulated radiation therapy (HIMRT) improves prostate cancer control compared with conventionally fractionated IMRT (CIMRT) for men with localized prostate cancer.Men were randomly assigned to 75.6 Gy in 1.8-Gy fractions delivered over 8.4 weeks (CIMRT) or 72 Gy in 2.4 Gy fractions delivered over 6 weeks (HIMRT, biologically equivalent to 85 Gy in 1.8-Gy fractions assuming prostate cancer α-to-β ratio of 1.5). Failure was defined as prostate-specific antigen (PSA) failure (nadir plus 2 ng/mL) or initiation of salvage therapy. Modified Radiation Therapy Oncology Group criteria were used to grade late (≥ 90 days after completion of radiotherapy) GI and genitourinary toxicity.Most of the 206 men (72%) had cT1, Gleason score 6 or 7 (99%), and PSA level ≤ 10 ng/mL (90%) disease. Androgen deprivation therapy was received by 24%. With a median follow-up of 8.5 years, men treated with HIMRT experienced fewer treatment failures (n = 10) than men treated with CIMRT (n = 21; P = .036). The 8-year failure rate was 10.7% (95% CI, 5.8% to 19.1%) with HIMRT and 15.4% (95% CI, 9.1% to 25.4%) with CIMRT. There was no difference in overall survival ( P = .39). There was a nonsignificant increase in late grade 2 or 3 GI toxicity with HIMRT (8-year 5.0% v 12.6%; P = .08). However, GI toxicity was only 8.6% when rectal volume receiving 65 Gy of HIMRT was ≤ 15%. Late genitourinary toxicity was similar ( P = .84). There was no grade 4 toxicity.The results of this randomized trial demonstrate superior cancer control for men with localized prostate cancer who receive dose-escalated moderately hypofractionation radiotherapy while shortening treatment duration." @default.
• W2885658755 created "2018-08-22" @default.
• W2885658755 creator A5037131932 @default.
• W2885658755 creator A5043231378 @default.
• W2885658755 creator A5046784671 @default.
• W2885658755 creator A5051028960 @default.
• W2885658755 creator A5053930355 @default.
• W2885658755 creator A5059988668 @default.
• W2885658755 creator A5069102269 @default.
• W2885658755 creator A5071173748 @default.
• W2885658755 creator A5073275198 @default.
• W2885658755 creator A5074288744 @default.
• W2885658755 creator A5075621917 @default.
• W2885658755 creator A5078458765 @default.
• W2885658755 creator A5082410046 @default.
• W2885658755 creator A5088529808 @default.
• W2885658755 date "2018-10-10" @default.
• W2885658755 modified "2023-10-16" @default.
• W2885658755 title "Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer" @default.
• W2885658755 cites W1970398327 @default.
• W2885658755 cites W1977970364 @default.
• W2885658755 cites W1990510898 @default.
• W2885658755 cites W2028742034 @default.
• W2885658755 cites W203234415 @default.
• W2885658755 cites W2043945205 @default.
• W2885658755 cites W2046812072 @default.
• W2885658755 cites W2054899405 @default.
• W2885658755 cites W2093867637 @default.
• W2885658755 cites W2098733695 @default.
• W2885658755 cites W2099288242 @default.
• W2885658755 cites W2111180711 @default.
• W2885658755 cites W2130514725 @default.
• W2885658755 cites W2131398800 @default.
• W2885658755 cites W2148664597 @default.
• W2885658755 cites W2160691516 @default.
• W2885658755 cites W2162480320 @default.
• W2885658755 cites W2337386322 @default.
• W2885658755 cites W2465092116 @default.
• W2885658755 cites W2469323349 @default.
• W2885658755 cites W2471689424 @default.
• W2885658755 cites W2520448081 @default.
• W2885658755 cites W2603384438 @default.
• W2885658755 cites W2741339193 @default.
• W2885658755 cites W4293241248 @default.
• W2885658755 doi "https://doi.org/10.1200/jco.2018.77.9868" @default.
• W2885658755 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6804854" @default.
• W2885658755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30106637" @default.
• W2885658755 hasPublicationYear "2018" @default.
• W2885658755 type Work @default.
• W2885658755 sameAs 2885658755 @default.
• W2885658755 citedByCount "80" @default.
• W2885658755 countsByYear W28856587552018 @default.
• W2885658755 countsByYear W28856587552019 @default.
• W2885658755 countsByYear W28856587552020 @default.
• W2885658755 countsByYear W28856587552021 @default.
• W2885658755 countsByYear W28856587552022 @default.
• W2885658755 countsByYear W28856587552023 @default.
• W2885658755 crossrefType "journal-article" @default.
• W2885658755 hasAuthorship W2885658755A5037131932 @default.
• W2885658755 hasAuthorship W2885658755A5043231378 @default.
• W2885658755 hasAuthorship W2885658755A5046784671 @default.
• W2885658755 hasAuthorship W2885658755A5051028960 @default.
• W2885658755 hasAuthorship W2885658755A5053930355 @default.
• W2885658755 hasAuthorship W2885658755A5059988668 @default.
• W2885658755 hasAuthorship W2885658755A5069102269 @default.
• W2885658755 hasAuthorship W2885658755A5071173748 @default.
• W2885658755 hasAuthorship W2885658755A5073275198 @default.
• W2885658755 hasAuthorship W2885658755A5074288744 @default.
• W2885658755 hasAuthorship W2885658755A5075621917 @default.
• W2885658755 hasAuthorship W2885658755A5078458765 @default.
• W2885658755 hasAuthorship W2885658755A5082410046 @default.
• W2885658755 hasAuthorship W2885658755A5088529808 @default.
• W2885658755 hasBestOaLocation W28856587552 @default.
• W2885658755 hasConcept C121608353 @default.
• W2885658755 hasConcept C126322002 @default.
• W2885658755 hasConcept C126894567 @default.
• W2885658755 hasConcept C133507102 @default.
• W2885658755 hasConcept C143998085 @default.
• W2885658755 hasConcept C155806632 @default.
• W2885658755 hasConcept C168563851 @default.
• W2885658755 hasConcept C2776235491 @default.
• W2885658755 hasConcept C2776694085 @default.
• W2885658755 hasConcept C2777899217 @default.
• W2885658755 hasConcept C2780192828 @default.
• W2885658755 hasConcept C2780775027 @default.
• W2885658755 hasConcept C2781406297 @default.
• W2885658755 hasConcept C2989005 @default.
• W2885658755 hasConcept C509974204 @default.
• W2885658755 hasConcept C71924100 @default.
• W2885658755 hasConceptScore W2885658755C121608353 @default.
• W2885658755 hasConceptScore W2885658755C126322002 @default.
• W2885658755 hasConceptScore W2885658755C126894567 @default.
• W2885658755 hasConceptScore W2885658755C133507102 @default.
• W2885658755 hasConceptScore W2885658755C143998085 @default.
• W2885658755 hasConceptScore W2885658755C155806632 @default.
• W2885658755 hasConceptScore W2885658755C168563851 @default.
• W2885658755 hasConceptScore W2885658755C2776235491 @default.
• W2885658755 hasConceptScore W2885658755C2776694085 @default.

• next